Miglustat 100 mg/1
Miglustat · CAPSULE · Navinta LLC
No Recall History
Plain English
Miglustat is a capsule containing miglustat at 100 mg/1, taken oral. Manufactured by Navinta LLC.
Key Facts
- Brand Name
- Miglustat
- Generic Name
- Miglustat
- NDC Code (Product)
68475-204- Manufacturer
- Navinta LLC
- Strength
- 100 mg/1
- Dosage Form
- CAPSULE
- Route
- ORAL
- Marketing Status
- Application #
- ANDA219111
- Drug Class
- Glucosylceramide Synthase Inhibitor [EPC]; Enzyme Stabilizer [EPC]
- Marketing Start
- 05/07/2025
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
seizure20 reports
diarrhoea19 reports
pneumonia18 reports
pyrexia10 reports
vomiting10 reports
pneumonia aspiration9 reports
dysphagia8 reports
respiratory failure8 reports
condition aggravated7 reports
cough7 reports
Frequently Asked Questions
What is Miglustat used for?
Miglustat contains Miglustat. It is a capsule taken oral. Consult your doctor for specific uses.
Is Miglustat a controlled substance?
Miglustat is not classified as a controlled substance by the DEA.
What is the generic name for Miglustat?
The generic name for Miglustat is Miglustat. There are 4 other brand versions of Miglustat.
What is the NDC code for Miglustat 100 mg/1?
The NDC (National Drug Code) for Miglustat 100 mg/1 is 68475-204, listed by Navinta LLC.